1-(5-Bromo-3-iodo-6-methyl-1H-indazol-1-yl)ethanone, 99%, 1g

3-BROMOIMIDAZO[5,1-B]THIAZOLE, 95.0%, 250mg

3-nitrofenol, mínimo 99 %, para síntesis, 100 g, envase de vidrio

(3-AMINOCYCLOBUTYL)ACETIC ACID, 95.0%, 5g

(3-tert-Butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid, 50mg

Estándar de agarosa, 10 g

2,6-Dichloro-4-methylaniline, 95.0%, 10g

2-Amino-5-chloro-2'-fluorobenzophenone, 98.0%, 100g

2-Hydroxypropyl methacrylate (mixture of 2-Hydroxypropyl methacrylate and 2-Hydroxy-1-methylethyl Methacrylate), 97% +(stabilized with MEHQ), 500g

N-(4-BROMO-2-IODOPHENYL)ACETAMIDE, 95.0%, 1g

(5-METHYL PYRIDIN-3-YL)METHAMINE HCL, 95.0%, 10g

ETHYL 1-TOSYLPIPERIDINE-3-CARBOXYLATE, 95.0%, 500mg

[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]amine oxalate, 95.0%, 10g